Use of Angiotensin Converting Enzyme Inhibitors and Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer

被引：0

作者：

Kerns, S. L. ^{[1
]}

Morlang, A. ^{[1
]}

Lee, S. M. ^{[2
]}

Hall, W. A. ^{[3
]}

Peterson, D. ^{[4
]}

Marples, B. ^{[1
]}

Zhang, H. ^{[1
]}

Bylund, K. C. ^{[1
]}

Rosenzweig, D. ^{[1
]}

de Ruyck, K. ^{[5
]}

Rosenstein, B. S. ^{[6
]}

Gomez CaamaNo, A. ^{[7
]}

Vega, A. ^{[8
]}

Parker, C. ^{[9
,10
]}

West, C. M. L. ^{[11
]}

Janelsins, M. ^{[12
]}

Chen, Y. ^{[1
]}

Messing, E. ^{[13
]}

Morrow, G. ^{[12
]}

机构：

[1] Univ Rochester, Dept Radiat Oncol, Rochester, NY USA

[2] Univ Rochester, Rochester, NY USA

[3] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA

[4] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA

[5] Univ Ghent, Ghent, Belgium

[6] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY USA

[7] H Clin Univ, Santiago De Compostela, Spain

[8] Univ Santiago de Compostela, Santiago De Compostela, Spain

[9] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[10] Inst Canc Res, Sutton, Surrey, England

[11] Univ Manchester, Manchester, Lancs, England

[12] Univ Rochester, Dept Surg, Canc Control, Rochester, NY USA

[13] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2566

引用

页码：E280 / E281

页数：2

共 50 条

[21] ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND THE RISK OF HEPATOCELLULAR CANCER: A NESTED COHORT ANALYSIS
Menon, Shyam
Mathew, Ray
GUT, 2021, 70 : A148 - A148
[22] Promoting use of angiotensin-converting-enzyme inhibitors
CookeAriel, H
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (03) : 264 - 264
[23] The clinical use of angiotensin-converting enzyme inhibitors
Wong, J
Patel, RA
Kowey, PR
PROGRESS IN CARDIOVASCULAR DISEASES, 2004, 47 (02) : 116 - 130
[24] USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF DEMENTIA IN HEART FAILURE
Chitnis, A. S.
Johnson, M. L.
Aparasu, R. R.
Chen, H.
Kunik, M. E.
Schulz, P. E.
VALUE IN HEALTH, 2013, 16 (03) : A11 - A11
[25] Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure
Chitnis, Abhishek S.
Aparasu, Rajender R.
Chen, Hua
Kunik, Mark E.
Schulz, Paul E.
Johnson, Michael L.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 395 - 404
[26] Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
Lever, AF
Hole, DJ
Gillis, CR
McCallum, IR
McInnes, GT
MacKinnon, PL
Meredith, PA
Murray, LS
Reid, JL
Robertson, JWK
LANCET, 1998, 352 (9123): : 179 - 184
[27] Predicting Radiotherapy Impact on Late Bladder Toxicity in Prostate Cancer Patients: An Observational Study
Catucci, Francesco
Alitto, Anna Rita
Masciocchi, Carlotta
Dinapoli, Nicola
Gatta, Roberto
Martino, Antonella
Mazzarella, Ciro
Fionda, Bruno
Frascino, Vincenzo
Piras, Antonio
D'Aviero, Andrea
Preziosi, Francesco
Palazzoni, Giovanni
Valentini, Vincenzo
Mantini, Giovanna
CANCERS, 2021, 13 (02) : 1 - 12
[28] Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
Hicks, Blanaid M.
Filion, Kristian B.
Yin, Hui
Sakr, Lama
Udell, Jacob A.
Azoulay, Laurent
BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
[29] Evaluation of Treatment With Angiotensin Converting Enzyme Inhibitors (ACEIs) and the Risk of Lung Cancer (ERACER)
Anderson, Jeffrey L.
Knowlton, Kirk U.
Muhlestein, Joseph B.
Bair, Tami L.
Lappe, Donald L.
Le, Viet T.
Biswas, Santanu
Horne, Benjamin D.
CIRCULATION, 2019, 140
[30] Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence
Khosravian, Maryam
Momenzadeh, Mahnaz
Koosha, Farzad
Alimohammadi, Niloufar
Kianpour, Neda
IMMUNOPATHOLOGIA PERSA, 2022, 8 (01):

← 1 2 3 4 5 →